Streetbeat News

Equity Actions

GILD

HOOK

HOOKIPA Pharma's stock price has risen following the announcement of a $21.25 million equity investment from Gilead Sciences.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 2:38 pm

WAVE

Eco Wave Power has submitted a request to the Swedish Financial Supervisory Authority to initiate a share buyback program for up to 10% of the company's shares.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 2:36 pm

PBLA

Panbela Therapeutics has entered into agreements with certain stockholders for a $2 million private placement. This involves the exercise of existing warrants for 2,556,000 shares of common stock at $0.78 per share, in exchange for new warrants.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 2:30 pm

FIHL

Fidelis Insurance has announced that its Board of Directors has approved a share repurchase program of $50 million. This program allows the company to repurchase its own shares, which can potentially increase the stock's value by reducing the number of shares available in the market and showing confidence in the company's financial health.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 2:17 pm

CPG

Crescent Point Energy has announced its intention to raise its quarterly base dividend by 15% annually, from $0.299 to $0.46.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 2:16 pm

GH

Guardant Health, Inc. (NASDAQ:GH) has announced a registered direct offering of 3,387,446 shares at $26.77 per share to Baillie Gifford, totaling approximately $90.7 million. The proceeds will be used for general corporate purposes, including working capital, operating expenses, and capital expenditures. The offering is pursuant to an automatic shelf registration statement on Form S-3 filed with the SEC. Guardant Health and Baillie Gifford express mutual support and look forward to a long-term partnership.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 2:07 pm

FNGR

Lind Partners has issued a statement regarding false allegations that they have taken naked short positions in FingerMotion, Inc. (NASDAQ:FNGR). They clarified their holdings, stating they own 3,215,296 shares, including shares issuable upon conversion of a convertible note, representing a 6.8% stake. They also hold 1,000 common shares with no other financial instruments related to FingerMotion. Lind Partners warns the public about misinformation spread by anonymous individuals for personal gain. They note FingerMotion's share price increased significantly since their investment.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 2:04 pm

SEIC

SEI (NASDAQ:SEIC) has acquired Altigo, a cloud-based technology platform for alternative investments. The acquisition aims to meet the growing demand for alternative assets, expected to reach $23 trillion by 2027, and streamline the investment process. SEI plans to integrate Altigo's capabilities with its own to provide a comprehensive solution for private fund investing, targeting the distribution of alternative investment products in a SaaS model to its clients by the first half of 2024. The financial terms of the deal were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 2:02 pm

WEN

Wendy's (NASDAQ:WEN) received mixed analyst ratings over the past three months, with no bullish, three somewhat bullish, and three indifferent ratings. The average 12-month price target is $22.17, a 13.06% decline from the previous average. Analysts from Stephens & Co., Barclays, Citigroup, Deutsche Bank, Wedbush, and Morgan Stanley have adjusted their ratings and price targets, reflecting changes in market dynamics and company performance. Wendy's is a major burger QSR in the U.S., with significant systemwide sales and a large number of units worldwide. The company's financials show strong net margin and ROE but a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 2:00 pm

CAKE

Cheesecake Factory (NASDAQ:CAKE) has been rated by 11 analysts in the past three months, with a shift towards a more bearish sentiment. The average 12-month price target is now $31.45, down 7.5% from previous estimates. Analysts from firms like Wedbush, Piper Sandler, Barclays, Stephens & Co., Deutsche Bank, Citigroup, Morgan Stanley, and B of A Securities have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. Cheesecake Factory's financial indicators show a mixed performance with strong revenue growth but challenges in profitability and debt management.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 2:00 pm